Skip to main content
QXL Diagnostics
Clinical Laboratory Data Governance

QXL Clinical Insights & Population Health Governance

A rigorous framework for anonymized, aggregated population health statistics, biomarker epidemiological trends, and diagnostic data verification derived directly from NABL accredited laboratory testing across Bengaluru.

NABL Accredited Quality (MC-6849) Strictly Anonymized Secondary LIS Data
Medical Review & LIS Audit Hold ActiveStatus: Rigorous Methodology Audit

Clinical Insights Medical Audit Notice

In accordance with QXL Diagnostics medical authority guidelines, all published population health statistics, sample sizes, and prevalence figures are subject to strict primary LIS (Laboratory Information System) data extraction and statistical validation.

Prior illustrative website copy and unverified statistical estimates have been withdrawn under a Medical Review Hold. Only fully validated, reproducible datasets with documented inclusion/exclusion criteria, exact sampling dates, and consultant pathologist review will be released on this portal.

Research Standards

QXL Laboratory Research Protocol

Every future clinical dataset published by QXL Diagnostics will strictly adhere to the following methodological criteria:

1. LIS Data Derivation

100% of sample counts, biological reference ranges, and prevalence figures are extracted directly from bidirectional LIS database queries run on calibrated analyzers.

2. Standardized Diagnostic Cutoffs

Diagnostic classifications follow precise clinical guidelines:

  • HbA1c Prediabetes: 5.7%–6.4% (ADA / WHO criteria)
  • HbA1c Diabetes: ≥6.5% (ADA / WHO criteria)
  • Vitamin D Deficiency: <20 ng/mL (Endocrine Society)
  • eGFR Impairment: <60 mL/min/1.73m² (KDIGO guidelines)

3. Patient Privacy & DPDP Compliance

All epidemiological queries undergo strict de-identification removing patient identifiers, names, phone numbers, and addresses in full compliance with DPDP 2023 guidelines.

4. Sampling & Limitation Transparency

Every study explicitly documents sampling window, age/gender distributions, inclusion/exclusion criteria, and sampling limitations (e.g. urban self-referred population bias).

5. Medical Director Sign-off

No population health report is published without prior review and authorization by Founder & Clinical Biochemist Dr. Shantakumar Muruda (MD) and consultant pathologists.

6. Verification Queries

Researchers and medical institutions seeking aggregated data for public health studies can contact our Quality & Research Desk at info@qxldiagnostics.com.

Looking for Clinical Diagnostic Testing?

Explore our NABL accredited test catalogue or learn more about our quality control protocols.